BCL2 and non-small cell lung carcinoma: Knockdown of ARID1A in non-small cell lung cancer (NSCLC) resulted in up-regulation of the expression of cycle-related proteins cyclinD1 and Bcl-2 and inhibition of apoptosis (34).